GENE ONLINE|News &
Opinion
Blog

Judy Ya-Hsuan Lin

Success is the ability to go from one failure to another with no loss of enthusiasm.

WRITTEN BY Judy Ya-Hsuan Lin

After Winning Approval for Its Painkiller in Thailand, Taiwan’s Lumosa Aims for Korea Nod
2022-01-02
argenx’s Novel Treatment for Myasthenia Gravis gets FDA Nod
2021-12-21
FDA Places Clinical Hold on Kura Oncology’s Acute Myeloid Leukemia Therapeutic
2021-11-25
Acrivon Therapeutics to Advance Proteomics Platform & Oncology Pipeline with $100M Series B Financing
2021-11-12
Parthenon Therapeutics Launches with $65 Million Series A to Advance Immuno-Oncology Treatment
2021-11-07
Cortexyme’s Shares Implode after Alzheimer’s Disease Drug Flunks Trial
2021-10-29
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
Biogen, Sage Pursue 2022 Filing for Depression Therapy, Zuranolone
2021-10-20
Axial Therapeutics to Advance Pipeline for Neurological Diseases with $37.25 Million Series C Funding
2021-10-17
Voyager Therapeutics’ Novel AAV Capsid Tech for Gene Therapy Attracts Pfizer’s Investment
2021-10-07
FDA Greenlights First and Only Treatment for Cholestatic Pruritus with ALGS
2021-10-04
858 Therapeutics Launches with $60 Million Series A for Advancing Small-Molecule Drugs
2021-09-23
Biogen Reports Positive Results for Non-Opioid Oral Pain Drug
2021-09-19
Serious Adverse Event in Study Participant Marks Latest Roadblock for Astellas’ Gene Therapy Trial
2021-09-03
FDA Approves Cara & Vifor’s CKD-Associated Pruritus Injection
2021-08-26
1 2 3 … 6
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top